Security · CUSIP 04280AAC4
ARROWHEAD PHARMACEUTICALS IN
NOTE 1/1 · institutional ownership from 13F filings
Q3 2026 is still being filed (deadline 45 days after quarter end), so holder counts are incomplete.
13F holders
2
Shares held
1.0M
Value held
$1.0M
New / sold out
0 / 0
Added / reduced
0 / 2
net -218.0K shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q3 2026
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of New York Mellon Corp | 900,000 | $930.2K | 0.00% |
| OPPENHEIMER ASSET MANAGEMENT INC. | 100,000 | $102.2K | 0.00% |
Biggest buyers
Nothing to show.
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Bank of New York Mellon Corp | Reduced | -215,000 | -19.3% |
| OPPENHEIMER ASSET MANAGEMENT INC. | Reduced | -3,000 | -2.9% |